[go: up one dir, main page]

NO20071706L - Koadministrering av Tigecycline og Digoxin. - Google Patents

Koadministrering av Tigecycline og Digoxin.

Info

Publication number
NO20071706L
NO20071706L NO20071706A NO20071706A NO20071706L NO 20071706 L NO20071706 L NO 20071706L NO 20071706 A NO20071706 A NO 20071706A NO 20071706 A NO20071706 A NO 20071706A NO 20071706 L NO20071706 L NO 20071706L
Authority
NO
Norway
Prior art keywords
tigecycline
digoxin
administration
administered
human
Prior art date
Application number
NO20071706A
Other languages
English (en)
Inventor
Donald G Raible
Gopal Muralidharan
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of NO20071706L publication Critical patent/NO20071706L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/65Tetracyclines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)

Abstract

Oppfinnelsen angår behandling av bakterieinfeksjoner med tigecyklin og hjerte- insuffisiens med digoksin ved koadministrering til et menneske med behov for dette.
NO20071706A 2004-10-28 2007-03-30 Koadministrering av Tigecycline og Digoxin. NO20071706L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62285904P 2004-10-28 2004-10-28
PCT/US2005/038410 WO2006060084A2 (en) 2004-10-28 2005-10-24 Coadministration of tigecycline and digoxin

Publications (1)

Publication Number Publication Date
NO20071706L true NO20071706L (no) 2007-05-24

Family

ID=36127476

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20071706A NO20071706L (no) 2004-10-28 2007-03-30 Koadministrering av Tigecycline og Digoxin.

Country Status (18)

Country Link
US (1) US20060094668A1 (no)
EP (1) EP1804807B1 (no)
JP (1) JP2008518911A (no)
KR (1) KR20070069182A (no)
CN (1) CN101039679A (no)
AT (1) ATE415973T1 (no)
AU (1) AU2005310306A1 (no)
BR (1) BRPI0517406A (no)
CA (1) CA2582089A1 (no)
CR (1) CR9073A (no)
DE (1) DE602005011468D1 (no)
EC (1) ECSP077423A (no)
IL (1) IL182681A0 (no)
MX (1) MX2007005163A (no)
NO (1) NO20071706L (no)
RU (1) RU2007112409A (no)
WO (1) WO2006060084A2 (no)
ZA (1) ZA200703441B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102512429A (zh) * 2005-03-14 2012-06-27 惠氏公司 替加环素组合物及制备方法
AR055336A1 (es) * 2005-06-16 2007-08-22 Wyeth Corp Proeso de elaboracion para la produccion de tigeciclina como un polvo reconstituible, polvo de tigeciclina liofilizado y producto hecho mediante el proceso
GB2461037A (en) * 2008-06-17 2009-12-23 Elias Bouras A method of treating alopecia using a composition comprising a cardiac glycoside
WO2010017273A2 (en) * 2008-08-06 2010-02-11 Wyeth Tigecycline formulations
MY195934A (en) 2017-01-27 2023-02-27 Neurocrine Biosciences Inc Methods for the Administration of Certain VMAT2 Inhibitors
CN111372567B (zh) 2017-09-21 2024-03-15 纽罗克里生物科学有限公司 高剂量的缬苯那嗪制剂和与其相关的组合物、方法和试剂盒
CN111836543A (zh) 2017-10-10 2020-10-27 纽罗克里生物科学有限公司 施用某些vmat2抑制剂的方法

Also Published As

Publication number Publication date
IL182681A0 (en) 2007-09-20
AU2005310306A1 (en) 2006-06-08
JP2008518911A (ja) 2008-06-05
KR20070069182A (ko) 2007-07-02
US20060094668A1 (en) 2006-05-04
CR9073A (es) 2007-08-28
ECSP077423A (es) 2007-05-30
EP1804807A2 (en) 2007-07-11
EP1804807B1 (en) 2008-12-03
WO2006060084A2 (en) 2006-06-08
WO2006060084A3 (en) 2006-07-20
RU2007112409A (ru) 2008-12-10
ZA200703441B (en) 2008-09-25
CA2582089A1 (en) 2006-06-08
CN101039679A (zh) 2007-09-19
BRPI0517406A (pt) 2008-10-07
MX2007005163A (es) 2007-06-26
ATE415973T1 (de) 2008-12-15
DE602005011468D1 (de) 2009-01-15

Similar Documents

Publication Publication Date Title
NO20070988L (no) Vaksine for forebygging og behandling av HIV-infeksjon
NO20064547L (no) Fremgangsmater for behandling av HIV infeksjon
DK2109602T3 (da) Tetracyclinderivater til behandling af bakterielle, virale og parasitiske infektioner
DK1773361T3 (da) Sammensætning baseret på probiotiske bakterier og anvendelse deraf til forebyggelse og/eller behandling af respiratoriske sygdomme og/eller infektioner og til forbedring af en intestinale funktionalitet
TN2010000137A1 (en) Spiropyrrolidines and their use against hcv and hiv infection
NO20071706L (no) Koadministrering av Tigecycline og Digoxin.
PL1951272T3 (pl) Zastosowanie lactobacillus do leczenia infekcji wirusowych
NO20081842L (no) Fremgangsmåter og sammensetninger for anvendelse ved behandling av pasienter med autoantistoff-positive sykdommer
NO20083202L (no) ANG2- og VEFG-inhibitorkombinasjoner
NO20074943L (no) Roflumilast for behandlingen av diabetes mellitus
EP2192901A4 (en) CHEMICAL AGENTS, COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF ORTHOPOXVIRUS INFECTIONS AND RELATED DISEASES
WO2008118849A3 (en) Hiv-1 protease inhibitors
DK1638589T3 (da) Kombinationsterapi med glatirameracetat og mitoxantron til behandling af multipel sklerose
NO20052362D0 (no) Fremgangsmater for administrering av dalbavancin for behandling av bakterielle infeksjoner
NO20072285L (no) S-mirtazapin for behandling av hetetokter
MX2009011930A (es) Terapia de combinacion para el tratamiento de infeccion de virus de hepatitis c.
DK1919466T3 (da) Formuleringer til behandling af lipoprotein-abnormiteter omfattende et statin og et methylnicotinamidderivat
DK1848415T3 (da) Kombinationsterapi med glatirameracetat og rasagilin til behandling af multipel sklerose
ZA200802934B (en) Use of lactobacillus for treatment of virus infections
NO20043445L (no) Kombinasjonsterapi for behandling av bakterielle infeksjoner
DK1635847T3 (da) Behandling af symptomer forbundet med bakteriel vaginose
DK1861080T3 (da) Idebenon til behandling af muskeldystrofier
NO20080495L (no) PEG-IFN-alfa og ribavirin for HBV-behandling
ATE433459T1 (de) Desoxo-nonadepsipeptide
DE502005008925D1 (de) Substituierte nonadepsipeptide

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application